Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
86 hedge funds and large institutions have $153M invested in Immunomedics Inc in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 14 closing their positions.
50% more call options, than puts
Call options by funds: $9.56M | Put options by funds: $6.38M
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
1% more funds holding
Funds holding: 85 → 86 (+1)
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
18% less capital invested
Capital invested by funds: $186M → $153M (-$32.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$6.52M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.17M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.3M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$903K |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$901K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.21M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.65M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.52M |
| 4 |
DM
Deerfield Management
New York
|
-$1.3M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1M |
IMMU Hedge Fund Activity: Q1 2015 in Review
86 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2015, worth a combined $153M — down 18% from $186M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IMMU positions and 14 closed out — a net gain of 2 holders — while 24 added to existing stakes and 25 trimmed.
The largest buyer was State of Wisconsin Investment Board, opening a new position worth an estimated $6.52M. The largest seller was TFS Capital, cutting an estimated $3.21M.
- 86 institutional investors held Immunomedics Inc (IMMU) as of Q1 2015, up from 85 in Q4 2014.
- Funds reported $153M of Immunomedics Inc stock for Q1 2015, down 18% quarter-over-quarter.
- 16 funds opened new Immunomedics Inc positions in Q1 2015 and 14 closed out, a net change of +2 holders.
- The largest Immunomedics Inc buyer in Q1 2015 was State of Wisconsin Investment Board, an estimated $6.52M added.
- The largest Immunomedics Inc seller in Q1 2015 was TFS Capital, an estimated $3.21M sold.
Based on aggregated 13F filings for Q1 2015.